BRIEF—China healthcare reform goals

China's state council has issued the national healthcare reform goals in the second half of 2018.

Among these aims is to ensure pharmaceutical supply situation for the country.

Specifically, China will continue to speed up the approval process for imported drugs, and seek to include more oncology drugs in the national reimbursement drug list.

Additionally, it says that the prices of drugs will continue to be slashed.

China will also update its essential drug list, which will focus on chronic disease drugs and reimbursement rates.